Omar Khalil

Omar Khalil

Director/Board Member at Solu Therapeutics

Health Technology
Commercial Services
Consumer Services

Profile

Omar Khalil is currently a Director at Geneos Therapeutics, Inc., a Director at Kestrel Therapeutics, Inc., a Director at Solu Therapeutics, Inc., a Partner at SHVMS, LLC, and a Board Member at MycRx.
Previously, he held positions as Vice President & US Hospital Products at Baxter International, Inc. from 2015 to 2017, Vice President & General Manager at Kaleo, Inc. from 2017 to 2020, and as a Principal at McKinsey & Co., Inc. He obtained his undergraduate and graduate degrees from the University of Michigan.

Omar Khalil active positions

CompaniesPositionStart
Private Equity Investor 01/01/2020
Director/Board Member 01/01/2022
Director/Board Member 01/01/2023
Director/Board Member 01/01/2021
Director/Board Member 01/01/2023
All active positions of Omar Khalil

Former positions of Omar Khalil

CompaniesPositionEnd
Private Equity Investor 01/01/2020
BAXTER INTERNATIONAL INC. Corporate Officer/Principal 01/01/2017
Corporate Officer/Principal -
See the detail of Omar Khalil's experience

Training of Omar Khalil

University of Michigan Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Omar Khalil's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
BAXTER INTERNATIONAL INC.

Health Technology

Private companies7

Health Technology

Commercial Services

Finance

Health Technology

Commercial Services

Commercial Services

Health Technology

See company connections